Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for DMAA. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 23 institutions reported holding DMAA, with 12.0 million shares worth $124.9 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Karpus Management | 2,507,817 | $27M | DECREASED |
| Mizuho Securities USA | 2,069,605 | $22M | INCREASED |
| Polar Asset Management Partners | 1,146,000 | $12M | DECREASED |
| Glazer Capital | 999,899 | $11M | DECREASED |
| Wolverine Asset Management | 832,093 | $9M | DECREASED |
Full institutional holdings, insider history, and congressional trades for Drugs Made In America Acquisition Corp. Ordinary Shares on SentiSense.